Table of Content

1.  Introduction
   1.1.  Market Definition
   1.2.  Market Ecosystem
   1.3.  Currency And Limitations
   1.4.  Key Stakeholders

2.  Research Methodology
   2.1.  Research Process
   2.2.  Process of Data Collection and Validation
      2.2.1.  Secondary Research
      2.2.2.  Primary Research
   2.3.  Market Sizing and Forecast
      2.3.1.  Market Size Estimation Approach
      2.3.2.  Market Share Analysis
      2.3.3.  Growth Forecast Approach
   2.4.  Assumptions for the Study

3.  Executive Summary

4.  Market Insights
   4.1.  Overview
   4.2.  Factors Affecting Market Growth
      4.2.1.  Impact Analysis of Market Dynamics
      4.2.2.  Factor Analysis
   4.3.  Pricing Analysis
   4.4.  Technology Trends
      4.4.1.  Emerging Sequencing Companies’ Focus on Improving Technologies and Reducing Costs
         4.4.1.1.  Singular Genomics Systems, Inc. (U.S.)
         4.4.1.2.  Ultima Genomics, Inc. (U.S.)
         4.4.1.3.  Element Biosciences (U.S.)
      4.4.2.  Key Market Players’ Emphasis on Portable and Real-Time Sequencing Technologies
   4.5.  Regulatory Analysis
      4.5.1.  North America
         4.5.1.1.  U.S.
      4.5.2.  Europe
      4.5.3.  Asia-Pacific
      4.5.4.  Latin America
      4.5.5.  Middle East
   4.6.  Porter’s Five Forces Analysis

5.  Whole Genome Sequencing Market Assessment?by Offering
   5.1.  Overview
   5.2.  Consumables
      5.2.1.  Sample Preparation Consumables
         5.2.1.1.  Library Preparation & Target Enrichment Consumables
         5.2.1.2.  Nucleic Acid Extraction & Amplification Consumables
         5.2.1.3.  Quality Control Consumables
         5.2.1.4.  Other Kits & Reagents
      5.2.2.  Other Consumables
   5.3.  Instruments
   5.4.  Software
   5.5.  Services

6.  Whole Genome Sequencing Market Assessment?by Sequencing Type
   6.1.  Overview
   6.2.  Large Whole-Genome Sequencing
   6.3.  Small Whole-Genome Sequencing
   6.4.  Phased Sequencing
   6.5.  Other Whole-Genome Sequencing Types

7.  Whole Genome Sequencing Market Assessment?by Application
   7.1.  Overview
   7.2.  Research & Other Applications
      7.2.1.  Drug Discovery
      7.2.2.  Agricultural & Animal Research
      7.2.3.  Other Applications
   7.3.  Clinical Applications
      7.3.1.  Oncology
      7.3.2.  Reproductive Health
      7.3.3.  Infectious Diseases
      7.3.4.  Other Clinical Applications

8.  Whole Genome Sequencing Market Assessment?by Technology
   8.1.  Overview
   8.2.  Sequencing by Synthesis (SBS)
   8.3.  Ion Semiconductor Sequencing
   8.4.  Single-Molecule Real-Time Sequencing
   8.5.  DNA Nanoball Sequencing
   8.6.  Other Whole Genome Sequencing Technologies

9.  Whole Genome Sequencing Market Assessment?by End User
   9.1.  Overview
   9.2.  Pharmaceutical & Biotechnology Companies
   9.3.  Hospitals & Diagnostic Laboratories
   9.4.  Academic & Research Institutes
   9.5.  Other End Users

10.  Whole Genome Sequencing Market Assessment?by Geography
   10.1.  Overview
   10.2.  North America
      10.2.1.  U.S.
      10.2.2.  Canada
   10.3.  Europe
      10.3.1.  Germany
      10.3.2.  France
      10.3.3.  U.K.
      10.3.4.  Italy
      10.3.5.  Spain
      10.3.6.  Rest of Europe
   10.4.  Asia-Pacific
      10.4.1.  China
      10.4.2.  Japan
      10.4.3.  India
      10.4.4.  Rest of Asia-Pacific
   10.5.  Latin America
      10.5.1.  Brazil
      10.5.2.  Mexico
      10.5.3.  Rest of Latin America
   10.6.  Middle East & Africa

11.  Competition Analysis
   11.1.  Overview
   11.2.  Key Growth Strategies
   11.3.  Competitive Benchmarking
   11.4.  Competitive Dashboard
      11.4.1.  Industry Leaders
      11.4.2.  Market Differentiators
      11.4.3.  Vanguards
      11.4.4.  Emerging Companies
   11.5.  Market Share Analysis (2023)
      11.5.1.  Illumina, Inc. (U.S.)
      11.5.2.  Thermo Fisher Scientific Inc. (U.S.)
      11.5.3.  MGI Tech Co., Ltd. (China)

12.  Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
   12.1.  Illumina, Inc. (U.S.)
   12.2.  Thermo Fisher Scientific Inc.
   12.3.  F. Hoffmann-La Roche Ltd
   12.4.  QIAGEN N.V.
   12.5.  Agilent Technologies, Inc.
   12.6.  Revvity, Inc.
   12.7.  Pacific Biosciences of California Inc.
   12.8.  Danaher Corporation
   12.9.  Oxford Nanopore Technologies Plc.
   12.10.  MGI Tech Co., Ltd.
               (Note: SWOT analyses of the top 5 companies will be provided.)

13.  Appendix
   13.1.  Available Customization
   13.2.  Related Reports



List of Figures

Figure 1?? ?Key Stakeholders?
Figure 2?? ?Research Process?
Figure 3?? ?Secondary Sources Referenced for This Study?
Figure 4?? ?Primary Research Techniques?
Figure 5?? ?Key Executives Interviewed?
Figure 6?? ?Breakdown of Primary Interviews (Supply-Side & Demand-Side)?
Figure 7?? ?Market Sizing and Growth forecast Approach?
Figure 8?? ?Global Whole Genome Sequencing Market, by Offering, 2024 Vs. 2031 (USD Million)?
Figure 9?? ?Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)?
Figure 10?? ?Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)?
Figure 11?? ?Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)?
Figure 12?? ?Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)?
Figure 13?? ?Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)?
Figure 14?? ?Global Whole Genome Sequencing Market: Impact Analysis of Market Drivers, Restraints, Opportunities, And Challenges (2024–2031)?
Figure 15?? ?Global Share of Cancer Cases, by Region, 2022 Vs. 2040 (%)?
Figure 16?? ?Pharmaceutical R&D Expenditures in The U.S., Europe, And China, 2010 Vs. 2020 Vs. 2021 (USD Million)?
Figure 17?? ?Global Pharmaceutical R&D Expenditure, 2014–2028 (USD Billion)?
Figure 18?? ?Percentage of Approved Personalized Medicines: Cancer Vs. Rare Diseases Vs. Other Diseases, 2022?
Figure 19?? ?USFDA Regulatory Pathways for IVD Kits?
Figure 20?? ?Eu Regulatory Pathway - IVDR 2017/746?
Figure 21?? ?China: Medical Device Classification and Premarket Requirements for IVD Products?
Figure 22?? ?Porter’s Five forces Analysis?
Figure 23?? ?Global Whole Genome Sequencing Market, by Offering, 2022 Vs. 2031 (USD Million)?
Figure 24?? ?Steps of Sample Preparation In A Typical Next-Generation Sequencing Workflow?
Figure 25?? ?Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)?
Figure 26?? ?Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)?
Figure 27?? ?U.S.: New Molecular Entity (NME) Approvals?
Figure 28?? ?Estimated Number of New Cancer Cases (Million)?
Figure 29?? ?Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)?
Figure 30?? ?Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)?
Figure 31?? ?Global Pharmaceutical R&D Spending, 2014-2026 (USD Million)?
Figure 32?? ?Pharmaceutical Spending In 2021 Vs. 2022 (In % of ?Health Spending)?
Figure 33?? ?Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)?
Figure 34?? ?North America: Whole Genome Sequencing Market Snapshot?
Figure 35?? ?U.S.: Pharmaceutical R&D Expenditure, 2014–2022 (USD Billion)?
Figure 36?? ?U.S.: Medical and Health R&D Investment Shares, by Source, 2020?
Figure 37?? ?Research Funding Supported by The Canadian Genomics Enterprise, 2022–2023 (%)?
Figure 38?? ?Genome Canada Funding Across Sectors, 2022-2023 (USD Million)?
Figure 39?? ?Europe: Pharmaceutical Industry R&D Expenditure, 2000–2022 (USD Million)?
Figure 40?? ?Europe: Whole Genome Sequencing Market Snapshot?
Figure 41?? ?Italy: Number of Biotechnology Firms, 2014-2022?
Figure 42?? ?Italy: Number of Biotechnology R&D-Dedicated Firms, 2014-2022?
Figure 43?? ?Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)?
Figure 44?? ?Asia-Pacific: Whole Genome Sequencing Market Snapshot?
Figure 45?? ?Japan: Pharmaceutical Industry R&D Expenditure, 2014-2022 (USD Million)?
Figure 46?? ?Japan: Number of New Molecular Entities Approved, 2014-2022?
Figure 47?? ?Latin America: Whole Genome Sequencing Market Snapshot?
Figure 48?? ?Key Growth Strategies Adopted by Leading Players, 2021– 2024?
Figure 49?? ?Global Whole Genome Sequencing Market: Competitive Benchmarking by Offering?
Figure 50?? ?Global Whole Genome Sequencing Market: Competitive Benchmarking, by Region?
Figure 51?? ?Competitive Dashboard: Global Whole Genome Sequencing Market?
Figure 52?? ?Global Whole Genome Sequencing Market Share Analysis, by Key Players, 2023 (%)?
Figure 53?? ?Illumina, Inc.: Financial Snapshot (2023)?
Figure 54?? ?Thermo Fisher Scientific Inc.: Financial Snapshot (2023)?
Figure 55?? ?F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)?
Figure 56?? ?QIAGEN N.V: Financial Snapshot (2023)?
Figure 57?? ?Agilent Technologies, Inc.: Financial Snapshot (2023)?
Figure 58?? ?Revvity, Inc.: Financial Snapshot (2023)?
Figure 59?? ?Pacific Biosciences of California Inc.: Financial Snapshot (2023)?
Figure 60?? ?Danaher Corporation: Financial Snapshot (2023)?
Figure 61?? ?Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)?
Figure 62?? ?MGI Tech Co., Ltd.: Financial Snapshot (2023)?